Navigation Links
Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis

manageable, chronic disease."

Within a year, Cleveland hopes the first clinical trial will be initiated in humans. In order to deliver the antisense drug directly to the nervous system, surgeons will insert a small pump into a patient using a fairly routine surgery that has already been approved for management of pain. A small catheter is then implanted into the area surrounding the spinal cord, in order to pump antisense oligonucleotide drugs directly into the nervous system.

The investigators noted that if the antisense approach works for ALS – by delivering therapeutic agents for neurodegenerative diseases across the highly impermeable blood-brain barrier – it would likely also work in other neurodegenerative conditions, including Alzheimer's, Parkinson's and Huntington's diseases.

"We know we're on target with the pathogenic mechanism," said Cleveland. The remaining question is whether the genetic-based therapy will be tolerated. "If tolerated, this sets the stage for broader treatment of neurodegenerative disease, especially Huntington's disease, where there is currently no treatment, but key genes involved in promoting disease are known."

Source :Eureka

'"/>




Page: 1 2 3

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
7. Molecular Basis Of ALS Found
8. New Molecular Treatment Identified To Treat Blood Cell Cancers
9. Researchers Find Molecular "Brake" to Cell Death
10. Solitons Could Power Molecular Electronics, Artificial Muscles
11. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases
Post Your Comments:
(Date:7/1/2015)... ... 2015 , ... During the first week of June, Alamo ... Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual Life ... learning and development professionals from more than 300 life sciences companies around the ...
(Date:7/1/2015)... ... July 01, 2015 , ... As if mood swings, cramps and child ... number of women: leg pain. Northeast Houston Vein Center is offering tips on the ... venous reflux disease, is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost ... was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , The ...
(Date:7/1/2015)... ... 01, 2015 , ... Boar’s Head Brand®, one of the ... Independence Day celebrations with new takes on classic dishes. From chicken salad with ... any summertime get together. , “Celebrating with family, friends, and great food is ...
(Date:7/1/2015)... ... ... Camp wasn’t always a steadfast supporter of plastic surgery. But just as her career ... a terrible car accident years ago left her injured and in need of reconstructive ... What if I Do?): Answers to All Your Questions about Plastic Surgery” (published by Archway ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2
... tilapia, one of the most highly consumed fish in ... acids and, perhaps worse, very high levels of omega-6 ... University School of Medicine. , The researchers say ... for some patients with heart disease, arthritis, asthma and ...
... in cases, experts say , , TUESDAY, July 8 (HealthDay News) ... pregnant does double or triple a woman,s risk, a new ... the sense that these are young women who are not ... Elkayam, a professor of medicine at the University of Southern ...
... Cardinal Health, a,global provider of products and ... care, today announced a consolidation of its,businesses into ... and align resources with the unique needs of ... and medical product,distribution centers and nuclear pharmacies will ...
... WASHINGTON, July 8 Michael E. Kerr, MD,Director of ... and a,psychiatrist in private practice, will address the topic ... has become one of the most widely,discussed and intensively ... reasons for a dramatic increase in the,number of children ...
... July 8 The Henry H. Kessler,Foundation, one ... announced today two key personnel changes that aim ... M.D., current President of Kessler,Medical Rehabilitation Research and ... DeLuca, Ph.D. will become the Vice President,for Research ...
... Health,s Document Management Solutions to Advance Efficiency and ... Statistics Office, CINCINNATI, July 8 Streamline ... that the Columbus Public,Health Vital Statistics Office will ... remote hosting services. As part of,their plan, the ...
Cached Medicine News:Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 2Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 3Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 4Health News:Pregnancy Boosts Heart Attack Risk 2Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 2Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 3Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 4Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 5Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 6Health News:The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary 2Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 2Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 3Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 4
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: